相关实验视频

Updated: Jul 20, 2026

Murine Prostate Micro-dissection and Surgical Castration

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

对人类割抵抗性前列腺癌的转录组分析:对新治疗策略的洞察力

Ramanjaneyulu Golla¹, Sneha Jaiswal¹, Anaswara Jayan¹

¹Dept. of Biochemistry, School of Allied Health Science, REVA University, Bangalore 560063, India.

Computational biology and chemistry

|April 18, 2025

概括

这项研究确定了驱动割抵抗性前列腺癌 (CRPC) 进展的关键基因. 研究结果揭示了新的治疗点和药物组合,以克服晚期前列腺癌治疗阻力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

前列腺癌是全球男性癌症死亡的主要原因之一.
抗雄激素剥夺疗法 (ADT) 是晚期前列腺癌的标准治疗方法,但往往会导致割抵抗性前列腺癌 (CRPC).
由于疾病的进展和治疗耐药性,CRPC存在重大治疗挑战.

研究的目的:

通过转录基因分析调查CRPC的遗传驱动因素.
确定CRPC的新型治疗点.
探索潜在的药物组合,以克服耐药性.

主要方法:

用RNA测序 (RNA-seq) 和生物信息学工具来分析基因表达.
确定了与瘤进展,细胞骨动力学和免疫调节相关的差异表达基因 (DEG).
进行了功能丰富分析和分子对接研究.

主要成果:

确定了包括 COL3A1, MYH4, FN1, ACTN1 和 CALR 在内的关键 DEG.
参与CRPC的重要途径包括actin-myosin丝滑动,信号,雄激素受体信号,免疫逃避和新陈代谢.
分子对接显示了CRPC基因 (ABCC4,FOLH1) 和潜在的配体 (flutamide,N-乙葡萄糖胺) 之间强大的结合.

结论:

转录组分析为CRPC进展的分子机制提供了洞察力.
已识别的基因和途径为新疗法提供了潜在的目标.
药物-联体相互作用表明了克服CRPC治疗耐药性的策略.

关键词:

雄激素剥夺疗法 (ADT) 是一种治疗方法.生物信息学是一种生物信息学.化抵抗性前列腺癌 (CRPC) 是一种癌症.免疫治疗是一种免疫疗法.多价类合物 (MPC) 是一种多价类合物.这是下一代测序.个性化医疗是个性化的医疗.前列腺癌是前列腺癌.

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...